Delivery Order SPE2DX22D0090-SPE2D826FAB2C
- Not listed
- This delivery order, awarded on October 14, 2025, represents a $1,639.62 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. The contract utilizes a non-competitive delivery order structure as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place...
- This delivery order, awarded on October 20, 2025, represents a $13,413.71 firm fixed-price contract to AmerisourceBergen Drug Corp for pharmaceutical and medical supply provision. The contract, which is a child award under a larger indefinite delivery vehicle, was issued by the Defense Logistics Agency's Medical Supply Chain division and is set to be completed by October 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This delivery order, awarded October 20, 2025, represents a $16,248.96 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is scheduled for completion by October 21, 2025, and will be performed at the awardee's corporate office location in Conshohocken, PA. This is a competitive award with no set-aside designation, reflecting...
- This delivery order, awarded on October 13, 2025, represents a $11,379.98 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. No set-aside designation...
- On October 14, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $664,450.32 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, which is scheduled for completion by October 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- On October 13, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $16,363.68 to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price, competitively awarded contract is scheduled for completion by October 14, 2025, and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- This delivery order, awarded October 13, 2025, represents a $33,832.92 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This...
- This delivery order, awarded on October 11, 2025, represents a $26,424 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain and AmerisourceBergen Drug Corp (CAGE 0U9U0) for pharmaceutical and medical supply delivery. The contract, which must be completed by October 14, 2025, is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 and extending through December 2026. This...
- This delivery order, awarded on October 20, 2025, represents a $6,963.84 firm fixed-price contract issued by the Defense Logistics Agency Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime...
- This delivery order, awarded October 20, 2025, represents a $107,300.80 firm fixed price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vehicle...
- SPE2DX22D0090Indefinite Delivery Contract
- SPE2DX22D0090-SPE2D826FAB2CDelivery Order
This delivery order, awarded on October 27, 2025, represents a $14,255.20 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's existing relationship with the federal government to procure pharmaceutical products and medical supplies for military healthcare systems. The contract is not set-aside and was competitively awarded, reflecting the vendor's demonstrated capability to meet federal procurement standards. Performance is scheduled for completion by October 28, 2025, with work performed at the company's Conshohocken location. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the underlying vehicle supporting this and similar delivery orders. This comprehensive pharmaceutical support contract enables the company to supply a wide range of medical commodities including brand-name and generic medications, vaccines, specialty drugs, and medical devices to support military healthcare programs globally. The DLA is currently planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving defense health requirements through competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 10/27/25 |